Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Moshe E Gatt

Showing results (21-30 of 90) with videos related to

Pageof 9
Sort By:
Journal of Clinical Medicine|April 12, 2022
Understanding the Bioactivity and Prognostic Implication of Commonly Used Surface Antigens in Multiple MyelomaEyal Lebel, Boaz Nachmias, Marjorie Pick, et al.
Cancer Medicine|November 24, 2021
Dose-adjusted EPOCH-R is not superior to sequential R-CHOP/R-ICE as a frontline treatment for newly diagnosed primary mediastinal B-cell lymphoma: Results of a bi-center retrospective studyYael Morgenstern, Shlomzion Aumann, Neta Goldschmidt, et al.
Anticancer Research|May 13, 2015
Thymidine kinase levels correlate with prognosis in aggressive lymphoma and can discriminate patients with a clinical suspicion of indolent to aggressive transformationMoshe E Gatt, Neta Goldschmidt, Ina Kalichman, et al.
Plos Medicine|April 15, 2009
Prolonged fever, hepatosplenomegaly, and pancytopenia in a 46-year-old womanLiran Levy, Abedelmajeed Nasereddin, Moshe Rav-Acha, et al.
Oncology Research and Treatment|December 9, 2020
Venous Thromboembolism Prophylaxis with Low-Molecular-Weight Heparin in Primary Central Nervous System LymphomaStav Gazal, Eyal Lebel, Yosef Kalish, et al.
Acta Haematologica|April 4, 2019
Romidepsin-Bendamustine Combination for Relapsed/Refractory T Cell LymphomaBoaz Nachmias, Adir Shaulov, David Lavie, et al.
Journal of Clinical Medicine|May 28, 2022
CD24 Is a Prognostic Marker for Multiple Myeloma Progression and SurvivalNoa Gross Even-Zohar, Marjorie Pick, Liron Hofstetter, et al.
British Journal of Haematology|May 17, 2018
The use of serum free light chain dimerization patterns assist in the diagnosis of AL amyloidosisMoshe E Gatt, Batia Kaplan, Dean Yogev, et al.
British Journal of Haematology|December 16, 2014
Phase I/II study exploring ImMucin, a pan-major histocompatibility complex, anti-MUC1 signal peptide vaccine, in multiple myeloma patientsLior Carmon, Irit Avivi, Riva Kovjazin, et al.
Leukemia & Lymphoma|October 21, 2016
The prognostic value of bone marrow involvement at the molecular level in aggressive lymphomaNeta Goldschmidt, Fares Darawshy, Geffen Kleinstern, et al.
Pageof 9

Showing results (21-30 of 90) with videos related to

Sort By:
Pageof 9
Journal of Clinical Medicine|April 12, 2022
Understanding the Bioactivity and Prognostic Implication of Commonly Used Surface Antigens in Multiple MyelomaEyal Lebel, Boaz Nachmias, Marjorie Pick, et al.
Cancer Medicine|November 24, 2021
Dose-adjusted EPOCH-R is not superior to sequential R-CHOP/R-ICE as a frontline treatment for newly diagnosed primary mediastinal B-cell lymphoma: Results of a bi-center retrospective studyYael Morgenstern, Shlomzion Aumann, Neta Goldschmidt, et al.
Anticancer Research|May 13, 2015
Thymidine kinase levels correlate with prognosis in aggressive lymphoma and can discriminate patients with a clinical suspicion of indolent to aggressive transformationMoshe E Gatt, Neta Goldschmidt, Ina Kalichman, et al.
Plos Medicine|April 15, 2009
Prolonged fever, hepatosplenomegaly, and pancytopenia in a 46-year-old womanLiran Levy, Abedelmajeed Nasereddin, Moshe Rav-Acha, et al.
Oncology Research and Treatment|December 9, 2020
Venous Thromboembolism Prophylaxis with Low-Molecular-Weight Heparin in Primary Central Nervous System LymphomaStav Gazal, Eyal Lebel, Yosef Kalish, et al.
Acta Haematologica|April 4, 2019
Romidepsin-Bendamustine Combination for Relapsed/Refractory T Cell LymphomaBoaz Nachmias, Adir Shaulov, David Lavie, et al.
Journal of Clinical Medicine|May 28, 2022
CD24 Is a Prognostic Marker for Multiple Myeloma Progression and SurvivalNoa Gross Even-Zohar, Marjorie Pick, Liron Hofstetter, et al.
British Journal of Haematology|May 17, 2018
The use of serum free light chain dimerization patterns assist in the diagnosis of AL amyloidosisMoshe E Gatt, Batia Kaplan, Dean Yogev, et al.
British Journal of Haematology|December 16, 2014
Phase I/II study exploring ImMucin, a pan-major histocompatibility complex, anti-MUC1 signal peptide vaccine, in multiple myeloma patientsLior Carmon, Irit Avivi, Riva Kovjazin, et al.
Leukemia & Lymphoma|October 21, 2016
The prognostic value of bone marrow involvement at the molecular level in aggressive lymphomaNeta Goldschmidt, Fares Darawshy, Geffen Kleinstern, et al.
Pageof 9